OssDsign AB (OSSD) AI Stock Analysis

1 Followers

OssDsign AB

(Nasdaq OMX AB:OSSD)

Select Model

Rating:46Neutral

Price Target:SEK 3.50▲(0.00% Upside)

Action:reiterated

Date:11/05/26

The score is held back primarily by weak financial performance: despite outstanding gross margins and a debt-free balance sheet, OssDsign is still loss-making with roughly SEK 60 million of annual cash burn and a recent TTM revenue decline of about 5%. Valuation offers little support given negative earnings and no dividend. Technicals are mixed — the price has recovered above its 20- and 50-day averages, but remains well below the 100- and 200-day averages, reflecting a longer-term downtrend. The strong equity cushion and clear trend of narrowing losses are the main positives that prevent a lower score.

Positive Factors

High Gross MarginsExceptionally high gross margins indicate attractive unit economics and provide substantial room to support operating expenses as the company scales. If revenue growth resumes and costs are controlled, this margin structure could help OssDsign convert improved commercial traction into stronger long-term profitability.

Negative Factors

Persistent Operating LossesDeeply negative EBIT and net income show that the company has not yet converted its attractive gross margins into sustainable profitability. Continued losses can constrain reinvestment, weaken shareholder returns, and increase the strategic importance of achieving sufficient scale and operating-cost discipline.

OssDsign AB (OSSD) vs. iShares MSCI Sweden ETF (EWD)

Market Cap: SEK 387.19M
Dividend Yield: ―
Average Volume (3M): 237.57K
Price to Earnings (P/E): -7.7
Beta (1Y): -0.63
Revenue Growth: -11.89%
EPS Growth: -11.85%
Country: Sweden
Employees: 38
Sector: General
Sector Strength: 55
Industry: Medical - Devices

OssDsign AB Business Overview & Revenue Model

Company Description

OssDsign AB (publ) specializes in the innovation, manufacturing, and distribution of advanced implant and material technologies crucial for bone regeneration. The company operates across a broad international market, including Sweden, Germany, the Un...

OssDsign AB Financial Statement Overview

Summary

OssDsign combines exceptional gross margins of 93–96% and a nearly debt-free balance sheet (SEK 283 million equity, SEK 0.7 million debt) with persistent unprofitability. TTM revenue of SEK 155.5 million produced a SEK 50.9 million net loss (-33% net margin), and free cash flow was negative SEK 61.6 million. Losses and cash burn have narrowed meaningfully since 2023, but a roughly 5% TTM revenue decline raises questions about growth durability, and continued burn erodes equity and could eventually require dilutive fundraising.

Income Statement

38Negative

Balance Sheet

77Positive

Cash Flow

27Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	155.51M	180.16M	133.94M	112.16M	56.98M	31.73M
Gross Profit	145.34M	173.47M	127.75M	83.64M	45.13M	20.84M
EBITDA	-52.98M	-44.30M	-44.40M	-122.02M	-89.41M	-79.97M
Net Income	-50.95M	-50.99M	-49.66M	-130.49M	-99.39M	-93.92M
Balance Sheet
Total Assets	358.25M	397.87M	307.42M	356.39M	339.50M	343.99M
Cash, Cash Equivalents and Short-Term Investments	138.06M	191.35M	100.86M	165.94M	124.65M	151.37M
Total Debt	698.00K	1.37M	1.97M	3.15M	13.60M	14.13M
Total Liabilities	75.36M	87.84M	93.36M	105.26M	91.39M	81.26M
Stockholders Equity	282.89M	310.03M	214.06M	251.13M	248.11M	262.72M
Cash Flow
Free Cash Flow	-61.55M	-71.43M	-63.04M	-94.03M	-89.36M	-89.84M
Operating Cash Flow	-48.82M	-64.03M	-62.38M	-93.91M	-89.23M	-89.78M
Investing Cash Flow	-24.29M	-7.40M	-657.00K	-124.00K	-129.00K	-51.85M
Financing Cash Flow	-163.00K	163.18M	-2.46M	135.40M	61.84M	243.43M

OssDsign AB Technical Analysis

Technical Analysis SentimentNegative

Last Price3.50

Price Trends

50DMA3.52Negative

100DMA3.78Negative

200DMA4.46Negative

Market Momentum

MACD0.04Negative

RSI48.09Neutral

STOCH43.46Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:OSSD, the sentiment is Negative. The current price of 3.50 is above the 20-day moving average (MA) of 3.49, below the 50-day MA of 3.52, and below the 200-day MA of 4.46, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 48.09 is Neutral, neither overbought nor oversold. The STOCH value of 43.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:OSSD.

OssDsign AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

SE:OSSD against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:XVIVO	64Neutral	SEK 6.39B	50.37	5.89%	―	17.83%	330.94%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
SE:BACTI.B	53Neutral	SEK 509.89M	85.28	1.93%	―	-0.51%	―
SE:SEDANA	49Neutral	SEK 894.03M	-26.31	-3.88%	―	0.42%	15.03%
SE:INTEG.B	46Neutral	SEK 242.30M	-5.70	-20.71%	―	1.43%	4.98%
SE:OSSD	46Neutral	SEK 387.19M	-7.74	―	―	-11.89%	-11.85%
SE:HEART	44Neutral	SEK 130.87M	-2.23	-54.68%	―	―	―

* General Sector Average

Performance Comparison

SE:OSSD and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SE:OSSD	OssDsign AB	3.50	-7.48	-68.12%
SE:XVIVO	Xvivo Perfusion AB	206.00	42.50	25.99%
SE:BACTI.B	Bactiguard Holding AB	15.35	-0.55	-3.46%
SE:INTEG.B	Integrum AB Class B	8.19	-0.04	-0.49%
SE:HEART	Scandinavian Real Heart AB	15.80	1.50	10.50%
SE:SEDANA	Sedana Medical AB	9.14	-0.37	-3.89%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026

OssDsign AB AI Stock Analysis